Correlation Between BioInvent International and Combigene

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BioInvent International and Combigene at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioInvent International and Combigene into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioInvent International AB and Combigene AB, you can compare the effects of market volatilities on BioInvent International and Combigene and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioInvent International with a short position of Combigene. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioInvent International and Combigene.

Diversification Opportunities for BioInvent International and Combigene

0.08
  Correlation Coefficient

Significant diversification

The 3 months correlation between BioInvent and Combigene is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding BioInvent International AB and Combigene AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Combigene AB and BioInvent International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioInvent International AB are associated (or correlated) with Combigene. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Combigene AB has no effect on the direction of BioInvent International i.e., BioInvent International and Combigene go up and down completely randomly.

Pair Corralation between BioInvent International and Combigene

Assuming the 90 days trading horizon BioInvent International AB is expected to under-perform the Combigene. In addition to that, BioInvent International is 1.12 times more volatile than Combigene AB. It trades about -0.36 of its total potential returns per unit of risk. Combigene AB is currently generating about -0.06 per unit of volatility. If you would invest  258.00  in Combigene AB on October 24, 2024 and sell it today you would lose (12.00) from holding Combigene AB or give up 4.65% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BioInvent International AB  vs.  Combigene AB

 Performance 
       Timeline  
BioInvent International 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BioInvent International AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Combigene AB 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Combigene AB are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Combigene unveiled solid returns over the last few months and may actually be approaching a breakup point.

BioInvent International and Combigene Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BioInvent International and Combigene

The main advantage of trading using opposite BioInvent International and Combigene positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioInvent International position performs unexpectedly, Combigene can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Combigene will offset losses from the drop in Combigene's long position.
The idea behind BioInvent International AB and Combigene AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stocks Directory
Find actively traded stocks across global markets
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.